Clover Health Investments, Corp.

CLOV Healthcare Healthcare Plans

Clover Health Investments, Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 40.3% from fiscal 2024. In the quarter to June 2026, revenue grew 55.6%, EPS grew 350.0% and free cash flow grew 406.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

4.48 0.20 −4.27%
Market cap
$2.5B
P/E
0.0×
Fwd P/E
292×
Dividend yield
—
F-score
3/9
Altman Z
0.44
Beneish M
−1.72
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
1.11 0.42 0.63 0.88
P/FCF ratio
37.01 16.85 0.00 0.00
P/Operating CF
109.05 8.52 (17.65) 129.64
P/B ratio
7.30 2.71 3.90 4.60
EV/Sales
1.02 0.33 0.57 0.78
EV/EBITDA
0.00 0.00 0.00 0.00
EV/FCF
34.03 13.51 (16.01) (16.07)
Current Ratio
1.50 1.33 1.47 1.71
Net Debt/EBITDA
(8.64) (7.43) 2.43 8.32
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
(0.95%) (6.82%) (7.34%) (3.68%)
Free Cash Flow Yield
2.70% 5.93% (5.73%) (5.51%)
Free Cash Flow per Share
0.05 0.21 (0.13) 0.02
Book value per Share
0.72 0.65 0.60 0.66
Free Cash Flow
24.51 107.04 (68.75) 11.41
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates